4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with nicotine in 1 studies
| Studies (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Trials (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Recent Studies (post-2010) (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Studies (nicotine) | Trials (nicotine) | Recent Studies (post-2010) (nicotine) |
|---|---|---|---|---|---|
| 42 | 0 | 9 | 28,519 | 2,280 | 9,302 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belluzzi, JD; Dao, JM; Leslie, FM; Loughlin, SE; McQuown, SC | 1 |
1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and nicotine
| Article | Year |
|---|---|
Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Autoradiography; Catecholamines; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Gene Expression Regulation; Limbic System; Locomotion; Male; Nicotine; Nicotinic Agonists; Piperazines; Protein Binding; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reward; RNA, Messenger; Self Administration; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Time Factors | 2011 |